Comment on: Effect of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia [2]

Atherosclerosis

Volumn 127, Issue 2, 1996, Pages 287-288

  Mikhailidis, D P ^a   Ganotakis, E S ^a   Winder, A F ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

plasma fibrinogen; pravastatin; simvastatin; type II hyperlipoproteinemia

Indexed keywords

ALBUMIN; FIBRINOGEN; PRAVASTATIN; SIMVASTATIN;

ATHEROGENESIS; DRUG EFFECT; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERLIPOPROTEINEMIA; LETTER; PRIORITY JOURNAL;

EID: 0030446609     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05956-4     Document Type: Letter

References (16)

1. Y Tsuda K Satoh M Kitadai Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia Atherosclerosis 122 1996 225 233
2. A Branchi A Rovellini D Sommariva AG Guliandolo A Fasoli Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia Thromb Haemostas 70 1993 241 243
3. A Kehely M MacMahon M Barbir Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia QJM 88 1995 421 427
4. M Farrer PH Winocour K Evans Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures Diab Res Clin Pract 23 1994 111 119
5. DR Illingworth S Bacon AS Pappu GJ Sexton Comparative hypolipidemic effects of lovastatin and simvastatin in patients with heterozygous familial hypercholesterolemia Atherosclerosis 96 1992 53 64
6. IF McDowell M Smye T Trinick Simvastatin in severe hypercholestrolaemia: a placebo controlled trial Br J Clin Pharmacol 31 1991 340 343
7. M Farnier F Bonnefous N Debbas A Irvine Comparative efficacy and safety of micronized fenofibrate and simvastat in patients with primary type IIa or IIb hyperlipidemia Arch Intern Med 154 1994 441 449
8. A Coumar JK Gill MA Barradas S O'Donoghue JY Jeremy DP Mikhailidis The effect of treatment with simvastatin on platelet function indices in hypercholesterolaemia J Drug Dev 4 1991 79 86
9. PM Sandset H Lund J Norseth U Abildgaard L Ose Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system Arterioscler Thromb 11 1991 138 145
10. M Halle A Berg J Keul MW Baumstark Association between serum fibrinogen concentrations and HDL and LDL subfraction phenotypes in healthy men Arterioscl Thromb Vasc Biol 16 1996 144 148
11. Y Tsuda K Satoh T Takahashi Effect of medication with pravastatin sodium on hemorheological parameters in patients with hyperlipoproteinemia Int Angiol 12 1993 360 364
12. DP Mikhailidis ES Ganotakis Plasma albumin and platelet function: relevance to atherogenesis and thrombosis Platelets 7 1996 125 137
13. H Wada Y Mori T Kaneko Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia Am J Hematol 44 1993 112 116
14. A Notarbartolo G Davi M Averna Inhibition of thomboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia Arterioscler Thromb Vasc Biol 15 1995 247 251
15. NJW Cheshire JHN Wolfe MA Barradas AW Chambler DP Mikhailidis Smoking and plasma fibrinogen, lipoprotein (a) and serotonin are markers for postoperative infrainguinal graft stenosis Eur J Vasc Endovasc Surg 11 1996 479 486
16. A Broijersen M Eriksson PT Larsson Effects of selective LDL-apheresis and pravastatin therapy on platelet function in familial hypercholesterolaemia Eur J Clin Invest 24 1994 488 498